HLA EXPLORE™ can help you in your COVID research and Omixon offers 50% off the annual licence fee for Research Institutions until the end of 2020

HLA Explore NGS software can analyze any experiment type – targeted exons, targeted whole genes, whole MHC, whole transcriptome, whole exome or whole genome – of your patient’s NGS samples.   While recovering from the COVID crises Omixon offers 50% off the annual licence fee for Research Institutions until the end...

 

Read more

Webinar – HLA Typing Uses in Research. How is HLA Explore Used to Facilitate it?

Join us for a Webinar on Tuesday, April 7 with Efi Melista (Head of Product, Omixon) who will be talking about the uses of HLA typing in research and population studies, and how Omixon’s HLA Explore can facilitate it. Examples in disease associations, pharmacogenetics, drug sensitivities and overall population genetics...

 

Read more

IT-Illuminating Talk with the Head of Software Development and Project Manager, Márton Pogány 

The following interview is part of the Omixon interview series that we are conducting with Key Opinion Leaders at Omixon. The next interviewee is the leader of  Omixon’s R&D team, Márton Pogány, Head of  Software Development and Project Manager, who gives us a glimpse of his project management techniques and the roles...

 

Read more

HLA Explore – New Genotyping Software for HLA by NGS

Omixon announce the public release of HLA Explore 1.4. HLA Explore is HLA genotyping software for genetics/genomics researchers for the analysis and interpretation of any NGS data. It is high-performance, high-throughput and high-resolution multi-sample software for genotyping analysis, interpretation and reporting. The software – featured to analyse data from any experiment...

 

Read more